Talking Medicines is using a familiar workplace challenge to sharpen the case for its employee insight offering. In its latest commentary on change communication, the company focuses on a problem that remains highly relevant for employers: as organisations move through repeated rounds of transformation, the volume of internal messaging rises, but clarity does not always keep pace.
New technologies, changing work models and shifting business priorities are creating an environment in which employees are regularly asked to adapt. Against that backdrop, Talking Medicines argues that communication has become a critical management function, not simply an administrative task.
It places the company’s PeopleVoice proposition in a category linked to execution risk inside large organisations. If change programmes are poorly understood, businesses can face slower adoption, weaker engagement and reduced confidence among staff. By aligning its offer with that pressure point, Talking Medicines is presenting its technology as part of the infrastructure needed to support organisational change more effectively.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.
